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STAT3This study aimed to investigate the role of therapeutic dexamethasone (Dex) treatment on the mechanisms
underlying chemokine expression during mild and severe acute pancreatitis (AP) experimentally induced in
rats. Regardless of the AP severity, Dex (1 mg/kg), administered 1 h after AP, reduced the acinar cell
activation of extracellular signal-regulated kinase (ERK) and c-Jun-NH2-terminal kinase (JNK) but failed to
reduce p38-mitogen-activated protein kinase (MAPK) in severe AP. In both AP models, Dex inhibited the
activation of nuclear factor-kappaB (NF-κB) and signal transducers and activators of transcription (STAT)
factors. All of this resulted in pancreatic down-regulation of the chemokines monocyte chemoattractant
protein-1 (MCP-1) and cytokine-induced neutrophil chemoattractant (CINC). Lower plasma chemokine
levels as well as decreased amylasemia, hematocrit and plasma interleukin-1β (Il-1β) levels were found
either in mild or severe AP treated with Dex. Pancreatic neutrophil inﬁltration was attenuated by Dex in mild
but not in severe AP. In conclusion, by targeting MAPKs, NF-κB and STAT3 pathways, Dex treatment down-
regulated the chemokine expression in different cell sources during mild and severe AP, resulting in
decreased severity of the disease.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Chemokines are important inﬂammatory mediators during (AP)
involved in the activation and migration of leukocytes into the tissues
[1]. On the structural basis, chemokines have been divided into
different groups according to the position of the ﬁrst two cysteine
residues [2]. CC chemokines (e.g. MCP-1) act as chemoattractants and
activators of non-polymorphonuclear leukocytes and CXC (e.g. CINC)
as chemoattractants of neutrophils. Increased plasma chemokine
levels have been reported in clinical [3,4] and experimental settings
[2,5-7] of AP. Overexpression of chemokines has been found in
pancreas of animals with experimentally induced AP [5,6,8,9] and also
isolated acinar cells were shown to produce chemokines as an early
signal in AP [6,10,11]. In addition, inﬁltrating leukocytes within the
pancreas [9] and circulating leukocytes [12] have also been reported
as cellular sources of chemokine production during AP. The type of
chemokine and pattern of expression vary in the different models of
AP and are not always related to the severity of the disease [6,8,10].
Glucocorticoids are used as anti-inﬂammatory and immunosup-
pressive agents in the treatment of inﬂammatory diseases by
interfering with the synthesis and activation of pro-inﬂammatory
factors. Nuclear factor-kappaB (NF-κB) and activator protein-1 (AP-1)armacología. Ediﬁcio Departa-
, Spain. Fax: +34 923 294673.
ll rights reserved.have shown to be targets for glucocorticoid-mediated repression of
inﬂammatory genes [13–15]. Also, interaction between glucocorti-
coids and signal transducers and activators of transcription (STAT)
factors regarding cytokine production has recently been reported
[16,17]. In addition, inhibition [18,19] and activation [20] of MAPK
signalling by glucocorticoids have also been reported in in vitro
studies; however, whether MAPKs play a signiﬁcant role in the anti-
inﬂammatory action of glucocorticoids has not yet been deﬁned in
vivo. Controversial results have been obtained when corticosteroids
have been applied in AP [12,21-30] and they are not currently
standard treatment for the disease. A better understanding of the
mechanism of action in AP would help to consider their use as
therapeutic strategy. On this basis, our aim was to examine the effect
of dexamethasone (Dex), a potent anti-inﬂammatory synthetic
corticosteroid, on the underlying signal pathways involved in the
acinar expression of two structurally different chemokines, MCP-1
and CINC, during AP and to assess the consequences in the
progression of the disease. The effectiveness of the Dx treatment
has been evaluated both in mild and severe models of AP.
2. Materials and methods
2.1. Chemicals
Dexamethasone 21-phosphate disodium salt (Dex), taurocholic
acid sodium salt hydrate, aminoacid mixture, bovine serum albumin
(BSA), collagenase type XI, soybean trypsin inhibitor (STI), N-(2-
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tomycin and penicillin solution, Nonidet P-40, aprotinin, leupeptin,
pepstatin, antipain, chymostatin, phenylmethanesulfonyl ﬂuoride
(PMSF), dithiothreitol (DTT) and buprenorphine, were supplied by
Sigma Chemical Co. (Madrid, Spain). MCP-1 and Il-1β enzyme-linked
immunosorbent assay (ELISA) kits were supplied by Bender MedSys-
tems (Vienna, Austria) and CINC ELISA kit was by R&D Systems
(Minneapolis, MN, USA). Agarose was supplied by Iberlabo (Madrid,
Spain). All other standard analytical grade laboratory reagents were
obtained from Merck (Madrid, Spain).
2.1.1. Animal models of pancreatitis and treatment
Male Wistar rats (250–300 g) were housed individually in cages
andmaintained at 22±1 °C using a 12-h light/dark cycle. The animals
were fasted overnight before the experiment but they were allowed
free access to water. All experiments were performed in accordance
with European Community guidelines on ethical animal research,
established by the European Community (86/609/EEC). The study
was approved by the Institutional Animal Care and Use Committee of
the University of Salamanca (Spain).
Under anaesthesia with 2%–3% isoﬂuorane, Forane® (Abott,
Madrid, Spain), mild AP was induced by bile-pancreatic duct
obstruction (BPDO), as previously described [31] and severe AP by
retrograde infusion of 3.5% sodium taurocholate (NaTc) into the bile-
pancreatic duct according to the method of Aho and Nevalainen [32].
Dexamethasone (Dex) was administered at a dose of 1 mg/kg by
intramuscular injection 1 h after inducing AP. Studies were carried out
at the following time periods: 3 h and 12 h in rats with BPDO-induced
AP and 3 h and 6 h in rats with NaTc-induced AP. Sixteen rats were
allocated in each experimental group and they were in turn
distributed in three subgroups to collect different kinds of samples:
cell lysates (n=5), RNA (n=5), pancreatic tissue and blood (n=6).
Postoperative analgesia was maintained by intramuscular injections
of buprenorphine (0.2 mg/kg). At the end of the experiments the
pancreas and blood samples were collected.
2.1.2. Analysis of phospho-MAPKs and IκBα
2.1.2.1. Preparation of total cell lysates. Acinar cells were isolated by
collagenase digestion at 20 °C as previously described [33]. They were
homogenized on ice in HEPES buffer, 10 mM, pH 7.9, containing 2 mM
EDTA, and 25 mM KCl and supplemented with 1 mM PMSF and a
protease inhibitor cocktail containing aprotinin, leupeptin, pepstatin,
antipain and chymostatin (5 μg/ml each). Themixturewasmaintained
on ice for 20min, afterwhich Nonidet P-40 (0.4%)was added for 2min
and then centrifuged at 4 °C for 3 min at 14,000×g. The supernatants
were collected and immediately stored at –80 °C until use.
2.1.2.2. Western blot analysis. Cytoplasmic extracts from acinar
cells (40 μg) were separated by 12% SDS–PAGE and electrophoreti-
cally transferred to a nitrocellulose membrane. Non-speciﬁc binding
was blocked by incubating the blot in Tris-buffered saline (TBS) pH
7.6, containing 0.1% (v/v) Tween 20 and 5% (w/v) non-fat drymilk for
1 h. Afterwards, blots were incubated overnight at 4 °C with the
primary antibody (at a 1:1000 dilutions in TBS buffer pH 7.6,
containing 0.1% (v/v) Tween 20 and 5% (w/v) BSA) against either
each of the three phospho-MAPKs: p38, extracellular signal-regulated
kinase (ERK1/2) and c-Jun NH2-terminal kinase (JNK), IκBα or β-actin
(Cell Signalling Technology, Beverly, MA). β-actin was used as the
load control of protein. After washing for 1 h with TBS containing 0.1%
Tween 20, the blots were incubated for 1 h at room temperature with
the respective horseradish peroxidase-conjugated secondary anti-
body at 1:2000 dilution in TBS buffer pH 7.6, containing 0.1% Tween
20 and 5% (w/v) non-fat dry milk and ﬁnally they were developed for
visualization. The bands were detected with the Phototope-HRP
Detection kit (Cell Signalling Technology, Beverly, MA). Image J 1.32software from http://rsbweb.nih.gov/ij/download.html was used to
quantify the intensity of the bands.
2.2. Determination of NF-κB- and STAT3-DNA binding
2.2.1. Nuclear cell extract preparation
Nuclear protein extracts were obtained from acinar cells using a
commercial nuclear extract kit following the recommendations of the
manufacturer (Active Motif, Rixensart, Belgium) and as was previ-
ously described [12].
NF-κB- and STAT3-DNA binding was measured in nuclear extracts
with the respective ELISA-based commercial kits (NF-κB p65 and
STAT3 TransAM assays, Active Motif, Rixensart, Belgium). Nuclear
proteins (5 μg),were added to eachwell coatedwith anoligonucleotide
containing the consensus binding site for either NF-κB or STAT3 and
incubated for 1 h. Activation was detected by incubation for 1 h with
the respective primary antibody: anti-NF-κB, which speciﬁcally
recognizes anepitope (p65) accessible onlywhen the factor is activated
andbound to its target DNA and anti-STAT3,which recognizes epitopes
only accessible when STAT3 is activated. A secondary anti-IgG
horseradish peroxidase conjugate allows detection of the activated
NF-κB and STAT3 by a colorimetric reaction. Absorbance was read
within 5 min at 450 nm with a reference wavelength of 655 nm.
2.3. Analysis of mRNA expression for MCP-1 and CINC
Total RNA was extracted from isolated acinar cells and pancreas
using RNAeasy kit treated with ampliﬁcation grade DNase 1 (Quiagen,
Valencia, Spain) according to the manufacturer's instructions. Purity
of RNA was veriﬁed by ethidium bromide staining on 1% agarose gels.
The purity of RNAwas assessed by a 260/280 ratio and the integrity of
RNA was veriﬁed by the presence of well-deﬁned 28S and 18S rRNA
bands.
Semiquantitative Reverse Transcriptase-Polymerase Chain Reaction
(RT-PCR) was performed to analyze mRNA expression of MCP-1 and
CINC in acinar cells and pancreas. Total RNA (1 μg) was reversed
transcribed by using 1st Strand cDNA synthesis kit (Roche). The cDNA
synthesized was used as template for PCR ampliﬁcation by using Taq
DNApolymerase, dNTPack (Roche). The followingprimer pairs (Roche)
were used: MCP-1 (sense: 5′-CACTATGCAGGTCTCTGTCACG-3′, anti-
sense; 5′-GACTCACTTGGTTCTGGTCCA-3′, product size: 294 bp), CINC
(sense: 5′-CTCCAGCCACACTCCAACAGA-3, antisense: 5′-CACCCTAA-
CACAAAACACGAT-3′, product size: 600 bp). Oligonucleotide primers
for β-actin (sense: 5′-CACGGCATTGTAACCAACTG-3′, antisense: 5′-
TCTCAGCTGTGGTGGTGAAG-3′, product size: 400 bp) were used as
internal control. PCRwas performed following procedures: 30 cycles of
denaturation at 94 °C for 30 s, annealing 56 °C for 45 s and elongation at
72 °C for 45 s. The ampliﬁed PCR products were separated on a 2%
agarose gel stained with ethidium bromide. The MCP-1, CINC and β-
actin PCR products were run together on the same gel in order to
normalize the band densities to the β-actin band which were
densitometrically quantiﬁed with a Gel Doc 1000/2000 image analysis
system (BioRad) using the QuantityOne software programme.
2.3.1. Blood analysis
Hematocrit was measured in blood samples. Amylase activity was
analyzed in plasma according to themethod of Hickson [34], as well as
IL-1β, MCP-1 and CINC concentrations using the respective ELISA kits
strictly following manufacturers' recommendations. All samples were
run in duplicated and averaged.
2.4. Myeloperoxidase (MPO) determination
Neutrophil inﬁltration was estimated in pancreas by measuring
tissue MPO activity, following the method of Bhatia and Hegde [7].
MPO activity is expressed as fold increase over controls.
Fig. 2. NF-κB activation in acinar cells of controls and rats with acute pancreatitis (AP)
induced either by bile-pancreatic duct obstruction (BPDO) or by 3.5% sodium
taurocholate (NaTc), untreated or treated with dexamethasone (Dex) given 1 h after
AP. (A) Representative Western blot of ﬁve experiments of IκBα and β-actin, as loading
control. (B) Mean values±SEM of p65 nuclear levels (measured as fold increase vs
controls) of ﬁve experiments. ANOVA followed by the Dunnett test showed signiﬁcant
differences vs controls (⁎⁎pb0.01, ⁎⁎⁎pb0.001) and vs untreated AP (♦♦pb0.01,
♦♦♦pb0.001).
Fig. 1. Phosphorylation of p38, extracellular signal-regulated kinases (ERK) and Jun N-terminal kinases in acinar cells of controls and rats with acute pancreatitis (AP) induced either
by bile-pancreatic duct obstruction (BPDO) or by 3.5% sodium taurocholate (NaTc), untreated or treated with dexamethasone (Dex) given 1 h after AP. Representative Western blots
of ﬁve experiments are shown. β-actin was used as loading control. Relative intensity of the bands in each group vs controls was considered in densitometric analysis. Results shown
are the means±SEM. ANOVA followed by the Dunnett test showed signiﬁcant differences vs controls (⁎pb0.05, ⁎⁎pb0.01, ⁎⁎⁎pb0.01) and vs untreated AP (♦pb0.05, ♦♦pb0.01,
♦♦♦pb0.001).
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Results are expressed as mean±SEM. Statistical analysis was
carried out using the analysis of variance (ANOVA) followed by the
Dunnett test to evaluate at each time point differences between
controls, untreated AP and Dx-treated AP. P values lower than 0.05
were considered to be signiﬁcant.
3. Results
3.1. Effect of dexamethasone on acute pancreatitis-induced
MAPK activity
The signiﬁcant increase in ERK and JNK phosphorylation found in
acinar cells from early stages of AP was signiﬁcantly reduced by Dex
treatment either in BPDO- or NaTc-induced AP. However, only in mild
but not in severe AP did Dex administration inhibited p38 phospho-
rylation. (Fig. 1).
3.2. Effect of dexamethasone on acute pancreatitis-induced NF-κB
and STAT3 activity
Analysis of NF-κB activation, evaluated by IκBα cytosolic concen-
trations (Fig. 2A) and p65 nuclear levels (Fig. 2B), revealed that Dex
administrationmaintained IκBα at control levels and inhibited NF-κB-
DNA binding either in BPDO- or NaTc-induced AP.
Both in the mild and the severe model of AP, STAT3 activity was
signiﬁcantly (pb0.05) attenuated in pancreatic acinar cells by Dex
treatment (Fig. 3).
Fig. 3. STAT3 activity in acinar cells of rats with acute pancreatitis (AP) induced either
by bile-pancreatic duct obstruction (BPDO) or by 3.5% sodium taurocholate (NaTc),
untreated or treated with dexamethasone (Dex) given 1 h after AP. Number of animals
in each group and AP period: 5. Results (fold increase vs controls) are shown as the
means±SEM. ANOVA followed by the Dunnett test showed signiﬁcant differences vs
controls (⁎⁎pb0.01, ⁎⁎⁎pb0.001) and vs untreated AP (♦pb0.05).
Fig. 4. mRNA expression of monocyte chemoattractant protein-1 (MCP-1) and
cytokine-induced neutrophil chemoattractant (CINC) in acinar cells of rats with acute
pancreatitis (AP) induced either by bile-pancreatic duct obstruction (BPDO) or by 3.5%
sodium taurocholate (NaTc), untreated or treated with dexamethasone (Dex) given
1 h after AP. A representative RT-PCR and the mean values±SEM (measured as fold
increase vs controls of MCP-1/β-actin and CINC//β-actin ratios). Number of animals in
each group and AP period: 5. ANOVA followed by the Dunnett test showed signiﬁcant
differences vs controls (⁎pb0.05, ⁎⁎pb0.01, ⁎⁎⁎pb0.001) and vs untreated AP
(♦pb0.05, ♦♦ pb0.01).
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The overexpression of MCP-1 and CINC mRNA found in pancreatic
acinar cells of rats with AP from early stages was signiﬁcantly
inhibited by Dex treatment either in BPDO or NaTc AP model (Fig. 4).
Analysis of chemokine expression in pancreatic tissue (Fig. 5)
revealed a signiﬁcant repression of the AP-induced MCP-1 and CINC
mRNA up-regulation in response to Dex administration, both in mild
and severe pancreatitis.
As Fig. 6 shows, the high levels of MCP-1 found in plasma of rats
with AP were signiﬁcantly reduced by Dex treatment both in mild and
severe AP. Dex treatment was effective to signiﬁcantly (pb0.05)
reduce CINC plasma levels during BPDO-induced AP and at early
stages in the NaTc model.
3.4. Effect of dexamethasone on the severity of acute pancreatitis
Hyperamylasemia and IL-1β plasma levels were signiﬁcantly
reduced by Dex administration, both in mild and severe AP (Fig. 7).
As Table 1 shows, hematocrit values were signiﬁcantly reduced
by Dex administration during BPDO-induced AP and at early stages
of NaTc-induced AP. Neutrophil inﬁltration in pancreas, evaluated
by MPO activity, was signiﬁcantly (pb0.01) reduced by Dex treat-
ment in BPDO-induced AP, but no effect was found in the severe
AP model.Fig. 5. mRNA expression of monocyte chemoattractant protein-1 (MCP-1) and
cytokine-induced neutrophil chemoattractant (CINC) in pancreatic tissue of rats with
acute pancreatitis (AP) induced either by bile-pancreatic duct obstruction (BPDO) or by
3.5% sodium taurocholate (NaTc), untreated or treated with dexamethasone (Dex)
given 1 h after AP. A representative RT-PCR and the mean values±SEM (measured as
fold increase vs controls of MCP MCP-1/β-actin and CINC//β-actin ratios). Number of
animals in each group and AP period: 5. ANOVA followed by Dunnett test showed
signiﬁcant differences vs controls (⁎pb0.05, ⁎⁎pb0.01) and vs untreated AP (♦pb0.05,
♦♦pb0.01, ♦♦♦pb0.001).
Fig. 7. Plasma amylase activity and Interleukin 1-β (IL-1β) in controls and rats with
acute pancreatitis (AP) induced either by bile-pancreatic duct obstruction (BPDO) or by
3.5% sodium taurocholate (NaTc), untreated or treated with dexamethasone (Dex)
given 1 h after AP. Number of animals in each group and AP period: 6. Results shown are
the means±SEM. ANOVA followed by the Dunnett test showed signiﬁcant differences
vs controls (⁎pb0.05, ⁎⁎pb0.01, ⁎⁎⁎pb0.001) and vs untreated AP (♦pb0.05, ♦♦pb0.01,
♦♦♦pb0.001).
Fig. 6. Plasma monocyte chemoattractant protein-1 (MCP-1) and cytokine-induced
neutrophil chemoattractant (CINC) concentrations in controls and rats with acute
pancreatitis (AP) induced either by bile-pancreatic duct obstruction (BPDO) or by 3.5%
sodium taurocholate (NaTc), untreated or treated with dexamethasone (Dex) given
1 h after AP. Number of animals in each group and AP period: 6. Results shown are the
means±SEM. ANOVA followed by the Dunnett test showed signiﬁcant differences vs
controls (⁎ pb0.05, ⁎⁎pb0.01, ⁎⁎⁎pb0.01) and vs untreated AP (♦pb0.05, ♦♦pb0.01).
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It is widely accepted that AP triggered by pancreatic activation of
trypsinogen within acinar cells [35] results in pancreatic damage
followed by a local and systemic inﬂammatory response in which
different mediators play a key role. On this basis the use of
glucocorticoids has been proposed because of their ability to interfere
with the cytokine network [36]. However, little attention has been
focused on studying the effects of glucocorticoids on the mechanisms
involved in the expression of chemokines, despite the fact they have
been shown to inﬂuence the leukocyte migration into the tissues and
to act as important regulators of leukocyte activation in situ [1]. The
effectiveness of glucocorticoids for the treatment of AP has been a
matter of dispute. Prophylactic administration has generally shown to
have protective effects on the injury induced in AP [21-26]; however,
both beneﬁcial [27,28] and inefﬁcient [29,30] results have been
reported for therapeutic treatments.
Our results indicated that Dex, given 1 h after inducing AP, at a
dose equivalent to that used in humans with AP [25], was able to
reduce the pancreatic expression of MCP-1 and CINC in rats with
either mild or necrotizing AP. Evidence that pancreatic acinar cells
themselves are able to activate MAPKs, NF-κB and STAT3 as signalling
mechanisms mediating chemokine expression has been previously
reported [5,6,11,16,37]. According to our results, these down-stream
pathways are targeted by Dex treatment, leading to a reduction in the
pancreatic acinar chemokine expression during AP. Regarding MAPK
activity, we demonstrate that irrespective of the severity of AP Dex
reduces JNK and ERK phosphorylation. However, only in mild but not
in severe AP was Dex treatment was able to inhibit p38 activity.
Failure in the Dex action on p38MAPK activity has been previously
reported in in vitro experiments using either lipopolysaccharide-
stimulated macrophages [19] or pancreatic acinar cells stimulated
with pancreatitis-associated ascitic ﬂuid [16]. It could be speculated
that different upstream MAPK-kinases (MKKs) may be not equallyaffected by Dex action. However, our study allows to compare two
settings in which p38MAPK activity is differently inﬂuenced by Dex
treatment in accordancewith the severity of AP. Environmental stress,
inﬂammatory cytokine and growth factors strongly activate the three
MAPKs. However, they have shown different behaviour in response to
ischemia–reperfusion. For an unknown reason JNK is not activated
during ischemia, but rather during reperfusion, whereas p38 is
activated during ischemia and remains active during reperfusion
[38,39]. Given that the BPDO model induces mild AP and NaTc model
necrotizing and hemorrhagic AP, we suggest that Dex treatment was
unable to hinder p38 MAPK activity in the severe AP model due to the
serious circulation impairment developed within the pancreas.
MAPKs have been demonstrated to act as upstream signals of NF-
κB and STAT3 activity [16,37,40], by promoting the phosphorylation of
the inhibitory protein IκBα and STAT3, respectively. Thus, the
negative cross-talk between Dex and MAPKs, may contribute, at
least in part, to reducing the activation of both transcription factors
found in Dex-treated rats. In addition, glucocorticoids are considered
anti-inﬂammatory agents by directly acting at transcriptional level to
repress genes encoding inﬂammatory factors. Two different mechan-
isms have been reported for glucocorticoids to explain their ability to
repress NF-κB activation: cross-coupling with p65 containing Rel-
related protein complexes and induction of IκBα synthesis [13,14].
Our results showed that Dex treatment up-regulated the synthesis of
IκBα inhibitory protein, thus maintaining NF-κB complex sequestered
in the cytoplasm complex. The fact that control values of p65 at
nuclear level were found in Dex-treated rats with either mild or
necrotizing AP is evidence of failure in the NF-κB translocation to the
nucleus. Inhibition of NF-κB activation by methylprednisolone [26] or
Dex [28] treatments in other AP models has been previously reported.
As a result of the negative cross-talk between Dex and the
transcription factors, down-regulation of chemokine expression was
found both in rats with mild or severe AP treated with Dex. These
results are in line with those obtained by Ramudo et al. [16] who,
using isolated acinar cells stimulated by pancreatitis-associated ascitic
Table 1
Hematocrit and myeloperoxidase (MPO) activity in pancreatic tissue in controls and rats with acute pancreatitis (AP) induced either by bile-pancreatic duct obstruction (BPDO) or
by 3.5% sodium taurocholate (NaTc), untreated or treated with dexamethasone (Dex).
Controls BPDO-AP NaTc AP
3 h 12 h 3 h 6 h
– Dex – Dex – Dex – Dex
Hematocrit (%) 43.72±0.38 49.59±0.65 46.50±0.29 48.86±0.54 44.77±0.72 54.49±0.26 51.47±0.70 54.52±0.88 53.83±1.58
a (pb0.01) a (pb0.01) a (pb0.01) b (pb0.01) a (pb0.001) a (pb0.01) a (pb0.01) a (pb0.01)
b (pb0.01) b (pb0.01)
MPO (fold increase vs controls) 1.00 0.94±0.27 1.12±0.11 5.20±0.46 1.52±0.31 8.50±1.67 8.60±1.01 12.96±1.49 11.45±0.95
a (pb0.01) b (pb0.01) a (pb0.01) a (pb0.01) a (pb0.001) a (pb0.01)
Number of animals in each group: 6. Results shown are the means±SEM. ANOVA followed by the Dunnett test showed signiﬁcant differences vs controls (a) and untreated AP (b).
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STAT3-mediated MCP-1 up-regulation by Dex.
In addition to acinar cells, chemokines may also be produced by
other cell types residing within the pancreas. Endothelial vascular
cells [41], stellate cells [42] and inﬁltrated leukocytes [9] may over-
express MCP-1 and CINC in response to local and circulating
cytokines, which would act as activating factors of NF-κB [43] and
STAT3 [44] transcription factors. Given that IL-1β was found to be
reduced in rats with AP treated with Dex, we suggest that chemokine
down-stream pathways might be impaired in these cell types due to
the cytokine down-regulation exerted by Dex treatment. Thereby,
Dex, given after inducing AP, becomes able to repress the pancreatic
chemokine expression during mild and severe AP, not only in acinar
but also in non-acinar cells.
Nevertheless, the analysis of MPO activity revealed that Dex
treatment was able to reduce the neutrophil inﬁltration in rats with
mild AP but failed in the severe model of AP. We suggest that the
intense oxidative stress triggered in the pancreas of rats with NaTc-
induced AP [6] may reduce the effectiveness of Dex in repressing the
leukocyte recruitment, given the powerful chemoattractant effect of
the reactive oxygen species [45].
The action of Dex treatment attenuating MAPK, NF-κB and STAT3
activity and thereby down-regulating chemokine expression results
in protection against AP as is also evidenced by lower hyperamyla-
semia and hematocrit values, ﬁndings which indicate certain
preservation of pancreatic exocrine function and less accumulation
of circulating ﬂuid in the tissues (edema), respectively. These effects
could be explained by some protective effects attributed to gluco-
corticoids besides the anti-inﬂammatory action, such as circulation
improvement [25] and stabilization of cytoskeleton proteins [46].
In summary, data obtained in two experimental models of AP
shows that Dex, with an early therapeutical window, may be
considered a potential strategy in the treatment of the disease by
targeting key signalling pathways in chemokine expression and
thereby preventing the progression of AP.
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